Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alfred

Showing results (391-400 of 434) with videos related to

Pageof 44
Sort By:
Clinical Epigenetics|June 2, 2018
Urine cell-based DNA methylation classifier for monitoring bladder cancerAntoine G van der Heijden, Lourdes Mengual, Mercedes Ingelmo-Torres, et al.
Urologic Oncology|September 19, 2016
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancerJ Alfred Witjes, Guido Dalbagni, Robert J Karnes, et al.
Genome Announcements|December 9, 2017
Genome Sequences of 19 <i>Rhodococcus erythropolis</i> Cluster CA PhagesJ Alfred Bonilla, Sharon Isern, Ann M Findley, et al.
Frontiers in Nuclear Medicine|October 2, 2024
An Update to the Pilot Study of <sup>177</sup>Lu-PSMA in Low Volume Hormone-Sensitive Prostate CancerBastiaan M Privé, Constantijn H J Muselaers, Inge M van Oort, et al.
Frontiers in Surgery|December 10, 2021
Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-AnalysisHongda Zhao, Vinson Wai-Shun Chan, Daniele Castellani, et al.
European Urology Open Science|April 8, 2024
The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing Intravesical System (TAR-200) in American Urological Association-defined Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: A Phase 1b StudyF Johannes P van Valenberg, Antoine G van der Heijden, Christopher J Cutie, et al.
European Urology|October 20, 2023
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesJ Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
Journal for Immunotherapy of Cancer|January 24, 2023
Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infectionsJelmer H van Puffelen, Boris Novakovic, Liesbeth van Emst, et al.
Nature Reviews. Urology|November 30, 2023
Clinical application of bladder MRI and the Vesical Imaging-Reporting and Data SystemValeria Panebianco, Alberto Briganti, Thierry N Boellaard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2020
Dose-Dependent Effect of Platinum-Based Chemotherapy on the Risk of Metachronous Contralateral Testicular CancerJoost M Blok, Harmke J Groot, Eline H Huele, et al.
Pageof 44

Showing results (391-400 of 434) with videos related to

Sort By:
Pageof 44
Clinical Epigenetics|June 2, 2018
Urine cell-based DNA methylation classifier for monitoring bladder cancerAntoine G van der Heijden, Lourdes Mengual, Mercedes Ingelmo-Torres, et al.
Urologic Oncology|September 19, 2016
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancerJ Alfred Witjes, Guido Dalbagni, Robert J Karnes, et al.
Genome Announcements|December 9, 2017
Genome Sequences of 19 <i>Rhodococcus erythropolis</i> Cluster CA PhagesJ Alfred Bonilla, Sharon Isern, Ann M Findley, et al.
Frontiers in Nuclear Medicine|October 2, 2024
An Update to the Pilot Study of <sup>177</sup>Lu-PSMA in Low Volume Hormone-Sensitive Prostate CancerBastiaan M Privé, Constantijn H J Muselaers, Inge M van Oort, et al.
Frontiers in Surgery|December 10, 2021
Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-AnalysisHongda Zhao, Vinson Wai-Shun Chan, Daniele Castellani, et al.
European Urology Open Science|April 8, 2024
The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing Intravesical System (TAR-200) in American Urological Association-defined Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: A Phase 1b StudyF Johannes P van Valenberg, Antoine G van der Heijden, Christopher J Cutie, et al.
European Urology|October 20, 2023
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesJ Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
Journal for Immunotherapy of Cancer|January 24, 2023
Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infectionsJelmer H van Puffelen, Boris Novakovic, Liesbeth van Emst, et al.
Nature Reviews. Urology|November 30, 2023
Clinical application of bladder MRI and the Vesical Imaging-Reporting and Data SystemValeria Panebianco, Alberto Briganti, Thierry N Boellaard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2020
Dose-Dependent Effect of Platinum-Based Chemotherapy on the Risk of Metachronous Contralateral Testicular CancerJoost M Blok, Harmke J Groot, Eline H Huele, et al.
Pageof 44